SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001171843-22-002658
Filing Date
2022-04-20
Accepted
2022-04-19 21:45:40
Documents
6
Period of Report
2022-05-31

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT def14a_041922.htm DEF 14A 667860
2 GRAPHIC logo.jpg GRAPHIC 8119
3 GRAPHIC cards_1.jpg GRAPHIC 314195
4 GRAPHIC cards_2.jpg GRAPHIC 237284
5 GRAPHIC cards_3.jpg GRAPHIC 313578
6 GRAPHIC cards_4.jpg GRAPHIC 237284
  Complete submission text file 0001171843-22-002658.txt   2199312
Mailing Address 251 CONSUMERS ROAD SUITE 1105 TORONTO A6 M2J 4R3
Business Address 251 CONSUMERS ROAD SUITE 1105 TORONTO A6 M2J 4R3 647-479-9828
Aptose Biosciences Inc. (Filer) CIK: 0000882361 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-32001 | Film No.: 22836206
SIC: 2836 Biological Products, (No Diagnostic Substances)